-
Forward Look
Many Cancers in HIV-Positive Patients Go UntreatedStudy suggests need to educate patients with HIV and their doctors.
by Kate Yandell
-
Forward Look
Do You Know BRCA?Learn more about educational efforts to increase understanding of the 'breast cancer' gene.
by Sue Rochman
-
Editor's Letter
Cancer and Watchful WaitingWatching and waiting for cancer to progress can be an alternative to active treatment.
by Kevin McLaughlin
-
Forward Look
Getting to the Root of Brain CancerQ&A with neurosurgeon Peter Dirks on stem cells and brain cancer.
by Chris Palmer
-
Forward Look
Cancer Centers Unite to Increase HPV Vaccination RatesJoint statement recommends girls and boys be vaccinated before age 13.
by Cameron Walker
-
Forward Look
Breast Cancer Survivors and Vaginal EstrogenExpert opinion affirms need to weigh risks and benefits.
by Kate Yandell
-
Forward Look
A Report Card on Active SurveillanceMany men with untreated prostate cancer are not getting proper follow-up.
by Heather Stringer
-
Forward Look
Radiation Appointments Are Numerous, And NecessaryNew study shows impact of missed treatments.
by Marilyn Fenichel
-
Treatment Is Waiting
For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
Cancer Talk
Most Cancer Survivors Don’t Meet Healthy Diet Goals
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon